Jean‐Paul Perreault

Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.

J. Curtis Nickel, Yves Fradet, Rex Boake et al. · PubMed · 1996 · 225 citations · Full text

Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer

Jochen Walz, Andrea Gallina, Paul Perrotte et al. · British Journal of Urology · 2007 · 138 citations

LONG-TERM FOLLOWUP OF INITIAL Ta GRADE 1 TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Bruno Leblanc, Alain Duclos, François Bénard et al. · The Journal of Urology · 1999 · 104 citations

A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy.

Robert Sabbagh, Michael McCormack, François Péloquin et al. · PubMed · 2004 · 101 citations

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years

Perry B. Hudson, Rex Boake, John Trachtenberg et al. · Urology · 1999 · 49 citations

Urology, Medicine, Benign Prostatic Hyperplasia +4